OQROSign up free
Insider trade

Charles River Laboratories (CRL): Director sold ~$8.41M

James C Foster, Director at Charles River Laboratories, sold ~$8.41M of Charles River Laboratories shares.

~$8.41M
Approx. value · 24K sh @ $350.00
32K
Holds after · shares reported
Traded
Oct 22, 2026
Filed
Oct 26, 2026

Context

Written by software from the filings listed below · Oct 26, 2026

  • What was filed. SEC Form 4 reports James C Foster, Director, sold 24,042 Charles River Laboratories (CRL) shares at $350.00 each, about $8.41M. The transaction was dated Oct 22, 2026; the Form 4 was filed on Oct 26, 2026, 4 days later.

5 more points, with the facts they come from, are in OQRO Pro.

Sign up free

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 28, 2026Federal contract · $5.3M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $5.31M obligated to date
  2. Aug 18, 2026Federal contract · $372K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $372K obligated to date
  3. Aug 25, 2026InsiderDirector sold ~$10.1M of CRL shares in the open market
  4. Aug 31, 2026Federal contract · $1.0M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $1.01M obligated to date
  5. Sep 8, 20265% stakeFMR LLC reported a passive stake (13G) of 10.2%
  6. Sep 17, 2026Federal contract · $2.7M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $2.68M obligated to date
  7. Sep 17, 2026Federal contract · $8.2M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $8.25M obligated to date
  8. Sep 25, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
  9. Oct 5, 2026InsiderOfficer sold ~$303K of CRL shares in the open market
  10. Oct 21, 2026InsiderOfficer sold ~$743K of CRL shares in the open market
  11. Oct 22, 2026 · this disclosureInsiderDirector sold ~$8.41M of CRL shares in the open market

What came next

  1. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
  2. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 12.4%
  3. Nov 10, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 3.9%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Charles River Laboratories

For Charles River Laboratories, OQRO holds 9 insider filings (SEC Form 4 or Form 144) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.

Other recent filings by James C Foster, Director

The full history of James C Foster, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Charles River Laboratories

Everything OQRO holds on this company is on its CRL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data